Tobacco
Compare Stocks
2 / 10Stock Comparison
XXII vs BTI
Revenue, margins, valuation, and 5-year total return — side by side.
Tobacco
XXII vs BTI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Tobacco | Tobacco |
| Market Cap | $119K | $125.93B |
| Revenue (TTM) | $19M | $51.78B |
| Net Income (TTM) | $-4M | $-10.75B |
| Gross Margin | -15.2% | 82.5% |
| Operating Margin | -62.0% | -26.8% |
| Forward P/E | — | 16.1x |
| Total Debt | $4M | $36.95B |
| Cash & Equiv. | $7M | $5.30B |
XXII vs BTI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| 22nd Century Group,… (XXII) | 100 | 0.0 | -100.0% |
| British American To… (BTI) | 100 | 144.9 | +44.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: XXII vs BTI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
XXII carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 48.1%, EPS growth 99.9%, 3Y rev CAGR -24.3%
- Lower volatility, beta 1.60, Low D/E 26.7%, current ratio 2.42x
- Beta 1.60, yield 100.0%, current ratio 2.42x
BTI is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 23 yrs, beta 0.24, yield 5.5%
- 40.8% 10Y total return vs XXII's -100.0%
- Beta 0.24 vs XXII's 1.60
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 48.1% revenue growth vs BTI's -5.2% | |
| Quality / Margins | -20.5% margin vs BTI's -20.8% | |
| Stability / Safety | Beta 0.24 vs XXII's 1.60 | |
| Dividends | 100.0% yield, vs BTI's 5.5% | |
| Momentum (1Y) | +37.9% vs XXII's -99.8% | |
| Efficiency (ROA) | -9.7% ROA vs XXII's -14.2%, ROIC 2.4% vs -81.4% |
XXII vs BTI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
XXII vs BTI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — XXII and BTI each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BTI is the larger business by revenue, generating $51.8B annually — 2666.6x XXII's $19M. Profitability is closely matched — net margins range from -20.5% (XXII) to -20.8% (BTI). On growth, XXII holds the edge at +80.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $19M | $51.8B |
| EBITDAEarnings before interest/tax | -$11M | -$9.5B |
| Net IncomeAfter-tax profit | -$4M | -$10.7B |
| Free Cash FlowCash after capex | -$8M | $18.7B |
| Gross MarginGross profit ÷ Revenue | -15.2% | +82.5% |
| Operating MarginEBIT ÷ Revenue | -62.0% | -26.8% |
| Net MarginNet income ÷ Revenue | -20.5% | -20.8% |
| FCF MarginFCF ÷ Revenue | -40.8% | +36.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +80.4% | -2.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +58.0% | +2.0% |
Valuation Metrics
XXII leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $118,791 | $125.9B |
| Enterprise ValueMkt cap + debt − cash | -$3M | $169.0B |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 31.40x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.08x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 21.29x |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 3.58x |
| Price / BookPrice ÷ Book value/share | 0.01x | 1.90x |
| Price / FCFMarket cap ÷ FCF | — | 9.73x |
Profitability & Efficiency
BTI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BTI delivers a -22.8% return on equity — every $100 of shareholder capital generates $-23 in annual profit, vs $-25 for XXII. XXII carries lower financial leverage with a 0.27x debt-to-equity ratio, signaling a more conservative balance sheet compared to BTI's 0.74x. On the Piotroski fundamental quality scale (0–9), BTI scores 7/9 vs XXII's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -25.0% | -22.8% |
| ROA (TTM)Return on assets | -14.2% | -9.7% |
| ROICReturn on invested capital | -81.4% | +2.4% |
| ROCEReturn on capital employed | -72.6% | +2.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.27x | 0.74x |
| Net DebtTotal debt minus cash | -$3M | $31.7B |
| Cash & Equiv.Liquid assets | $7M | $5.3B |
| Total DebtShort + long-term debt | $4M | $37.0B |
| Interest CoverageEBIT ÷ Interest expense | -10.14x | 3.79x |
Total Returns (Dividends Reinvested)
BTI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BTI five years ago would be worth $18,342 today (with dividends reinvested), compared to $0 for XXII. Over the past 12 months, BTI leads with a +37.9% total return vs XXII's -99.8%. The 3-year compound annual growth rate (CAGR) favors BTI at 23.7% vs XXII's -99.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -94.6% | +4.2% |
| 1-Year ReturnPast 12 months | -99.8% | +37.9% |
| 3-Year ReturnCumulative with dividends | -100.0% | +89.4% |
| 5-Year ReturnCumulative with dividends | -100.0% | +83.4% |
| 10-Year ReturnCumulative with dividends | -100.0% | +40.8% |
| CAGR (3Y)Annualised 3-year return | -99.0% | +23.7% |
Risk & Volatility
BTI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BTI is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than XXII's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BTI currently trades 91.9% from its 52-week high vs XXII's 0.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.60x | 0.24x |
| 52-Week HighHighest price in past year | $455.40 | $63.22 |
| 52-Week LowLowest price in past year | $0.67 | $40.12 |
| % of 52W HighCurrent price vs 52-week peak | +0.2% | +91.9% |
| RSI (14)Momentum oscillator 0–100 | 15.1 | 56.9 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 4.4M |
Analyst Outlook
Evenly matched — XXII and BTI each lead in 1 of 2 comparable metrics.
Analyst Outlook
For income investors, XXII offers the higher dividend yield at 100.00% vs BTI's 5.49%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $40.00 |
| # AnalystsCovering analysts | — | 18 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +5.5% |
| Dividend StreakConsecutive years of raises | 0 | 23 |
| Dividend / ShareAnnual DPS | $25.42 | $2.34 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.9% |
BTI leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). XXII leads in 1 (Valuation Metrics). 2 tied.
XXII vs BTI: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is XXII or BTI a better buy right now?
For growth investors, 22nd Century Group, Inc.
(XXII) is the stronger pick with 48. 1% revenue growth year-over-year, versus -5. 2% for British American Tobacco p. l. c. (BTI). British American Tobacco p. l. c. (BTI) offers the better valuation at 31. 4x trailing P/E (16. 1x forward), making it the more compelling value choice. Analysts rate British American Tobacco p. l. c. (BTI) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — XXII or BTI?
Over the past 5 years, British American Tobacco p.
l. c. (BTI) delivered a total return of +83. 4%, compared to -100. 0% for 22nd Century Group, Inc. (XXII). Over 10 years, the gap is even starker: BTI returned +40. 8% versus XXII's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — XXII or BTI?
By beta (market sensitivity over 5 years), British American Tobacco p.
l. c. (BTI) is the lower-risk stock at 0. 24β versus 22nd Century Group, Inc. 's 1. 60β — meaning XXII is approximately 563% more volatile than BTI relative to the S&P 500. On balance sheet safety, 22nd Century Group, Inc. (XXII) carries a lower debt/equity ratio of 27% versus 74% for British American Tobacco p. l. c. — giving it more financial flexibility in a downturn.
04Which is growing faster — XXII or BTI?
By revenue growth (latest reported year), 22nd Century Group, Inc.
(XXII) is pulling ahead at 48. 1% versus -5. 2% for British American Tobacco p. l. c. (BTI). On earnings-per-share growth, the picture is similar: British American Tobacco p. l. c. grew EPS 121. 0% year-over-year, compared to 99. 9% for 22nd Century Group, Inc.. Over a 3-year CAGR, BTI leads at 0. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — XXII or BTI?
British American Tobacco p.
l. c. (BTI) is the more profitable company, earning 11. 9% net margin versus -28. 7% for 22nd Century Group, Inc. — meaning it keeps 11. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTI leads at 10. 6% versus -64. 9% for XXII. At the gross margin level — before operating expenses — BTI leads at 82. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — XXII or BTI?
All stocks in this comparison pay dividends.
22nd Century Group, Inc. (XXII) offers the highest yield at 100. 0%, versus 5. 5% for British American Tobacco p. l. c. (BTI).
07Is XXII or BTI better for a retirement portfolio?
For long-horizon retirement investors, British American Tobacco p.
l. c. (BTI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 24), 5. 5% yield). 22nd Century Group, Inc. (XXII) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BTI: +40. 8%, XXII: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between XXII and BTI?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: XXII is a small-cap high-growth stock; BTI is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Consumer Defensive
- Market Cap > $20B
- Revenue Growth > 40%
- Dividend Yield > 40.0%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.